The meeting is routine, but the recent appointment of Habib Dable and the election of two other new directors (Moran and More) suggest potential shifts in board composition. Monitor for any unexpected outcomes in the vote, though the board's recommendation is for approval.
Price Chart
Executive Summary
Tyra Biosciences is holding its annual shareholder meeting to elect three directors, including Habib J. Dable, whose recent appointment was previously disclosed. The board recommends voting for all proposals, including the ratification of Ernst & Young as auditors. This filing follows recent board changes, suggesting ongoing governance activity.
Key Facts
- The annual meeting will be held on May 28, 2026.
- Three directors are up for election: Habib J. Dable, Susan Moran, and Robert More.
- Ernst & Young LLP is up for ratification as the independent auditor.
- The board recommends a vote FOR all proposals.
- Habib J. Dable was recently appointed to the board on April 16, 2026, as disclosed in an 8-K filing.
Financial Impact
None disclosed.
Risk Factors
- Potential for shareholder dissent on director elections, though the board recommends approval.
- Recent board changes could indicate internal strategy shifts or governance issues.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-160364 |
| Document: 0001193125-26-160364-index-headers.html | 0001193125-26-160364 |
| Document: 0001193125-26-160364-index.html | 0001193125-26-160364 |
| Document: 0001193125-26-160364.txt | 0001193125-26-160364 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | S-3ASR | $25.07 $25.65 | ▲ +2.31% | ▲ +2.21% | $20.50 (−18.21%) |
Sep 9, 2026 23d ago | 8-K | $22.01 $24.35 | ▲ +10.63% | ▲ +11.73% | $20.50 (−6.84%) |
Aug 4, 2026 8w ago | 424B5 | $25.71 $25.30 | ▲ +1.59% | ▲ +1.95% | $20.50 (+20.25%) |
Jun 26, 2026 13w ago | 144 | $32.11 $30.86 | ▲ +3.89% | ▲ +5.28% | $20.50 (+36.14%) |
May 13, 2026 20w ago | 8-K | $36.19 $33.78 | ▼ −6.66% | ▼ −5.50% | $20.50 (−43.34%) |
Apr 20, 2026 23w ago | 3 | $36.69 $35.06 | ▼ −4.44% | ▼ −5.53% | $20.50 (−44.11%) |
Apr 17, 2026 24w ago | DEFA14A | $35.56 $37.59 | ▲ +5.71% | ▲ +5.15% | $20.50 (−42.34%) |
Apr 17, 2026 24w ago | 8-K | $35.56 $37.59 | ▲ +5.71% | ▲ +5.15% | $20.50 (−42.34%) |
Apr 13, 2026 24w ago | 144 | $35.27 $36.69 | ▲ +4.03% | ▲ +2.63% | $20.50 (−41.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access